Systematic production of human kidney organoids for transplantation in porcine kidneys during ex vivo machine perfusion
Elena Garreta(Institute for Bioengineering of Catalonia), Núria Montserrat(Institució Catalana de Recerca i Estudis Avançats), Asier Ullate‐Agote(Centro de Investigación Médica Aplicada), Juan R. Rodríguez-Madoz(Centro de Investigación Médica Aplicada), Jordi Ochando(Tisch Cancer Institute), Carlos J. Aranda(Universidad de Granada), Felipe Prósper(Institute of Human Genetics), Cyril Moers(University Medical Center Groningen), Margarita González‐Martín(Instituto de Investigación Biomédica de A Coruña), Beatriz Domínguez‐Gil(Universidad de Zaragoza), Maarten Naesens(KU Leuven), Cristóbal Belda-Iniesta(Instituto de Salud Carlos III), Roger Oria(University of California, San Francisco), Daniel Lozano‐Ojalvo(Child Health and Development Institute), Daniel Moya‐Rull(Institute for Bioengineering of Catalonia), Javier Rodríguez-Rivera(Instituto de Investigación Biomédica de A Coruña), Carolina Tarantino(Institute for Bioengineering of Catalonia), Aleix Gavaldà‐Navarro(Universitat de Barcelona), Idoia Lucía Selfa(Institute for Bioengineering of Catalonia), Alejandro Montero Salinas(Yahoo (Spain)), Priyanka Koshy(KU Leuven), Federico Gonzãlez(Institute for Bioengineering of Catalonia), Tim L. Hamelink(University Medical Center Groningen), Patrícia Martin(Instituto de Investigación Biomédica de A Coruña), Amaia Vilas‐Zornoza(Clinica Universidad de Navarra), Andrés Marco(Institute for Bioengineering of Catalonia), Merel B. F. Pool(University Medical Center Groningen), Antón Fernández García, Alberto Centeno(Universidade da Coruña), Gaia Amato(Institute for Bioengineering of Catalonia), Inmaculada Márquez-Leiva(Instituto de Salud Carlos III), Henri G. D. Leuvenink(Network for Earthquake Engineering Simulation)
Cited by 14
Related Papers
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
|Cell|2020|2.3k
Calcineurin Inhibitor Nephrotoxicity
|Clinical Journal of the American Society of Nephrology|2009|1.5k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809